Clinical studies on pharmacological therapies for MC4R -deficient obesity Before reviewing individual pharmacological agents, it is essential to acknowledge the inherent limitations of the evidence supporting their use, specifically in MC4R -deficient obesity
Does calorie restriction induce mitochondrial biogenesis
As with most regenerative therapies, periodic breaks and monitoring are part of a responsible protocol
It can alleviate inflammatory responses in specific conditions, such as periodontal (tooth) disease, and counteract tissue damage associated with prolonged use of NSAIDs, thereby reducing systemic stress and promoting overall healing
Given the huge unmet need and major health challenges, the negative trial results are very disappointing, and a sobering reminder that GLP-1 medicines will not be helpful for every medical condition, Daniel Drucker, an endocrinologist at the Lunenfeld-Tanenbaum Research Institute and a recent winner of the 2025 Breakthrough Prize in Life Sciences for his role in the development of GLP-1 agonists, told DDN
